Browse the evidence

The combination of long-acting PYY analogs with a GLP-1 receptor agonist resulted in superior blood glucose lowering and greater body weight loss compared to GLP-1 alone.

Suggests a potential strategy for enhanced diabetes and obesity treatment.

Patients exhibited initial physical functioning scores below the reference values yet demonstrated substantial physical recuperation by the 12-week mark following their ICU discharge in both groups.

Nutrition interventions may play a crucial role in recovery for post-ICU patients.

Moderate-quality evidence revealed beneficial relationships between the intake of omega-6 fatty acids and cardiovascular disease (CVD) mortality, overall cancer mortality, and all-cause mortality.

Increasing omega-6 fatty acid intake may reduce risks of CVD and cancer.

Moderate-quality evidence suggested that seafood-derived omega-3 fatty acids were associated with reduced triglyceride levels, elevated high density lipoprotein cholesterol, and a decreased risk of coronary heart disease.

Encouraging seafood consumption may improve heart health and lipid profiles.

A significant global prevalence of inadequate omega-6 and seafood omega-3 fatty acid intakes exists, particularly in less-developed regions.

Efforts should be made to improve omega-6 and omega-3 intake in less-developed areas.

Management strategies for weight regain include lifestyle interventions, pharmacotherapy, and revisional surgery.

A multidisciplinary approach incorporating these strategies is essential for effective long-term weight management.

Myofibrillar protein synthesis rates did not differ between omnivorous and vegan dietary patterns.

Both omnivorous and vegan diets can support similar rates of muscle protein synthesis during resistance training.

These therapies may reduce the risk for HF hospitalizations.

Incorporating these therapies may help reduce hospital admissions for heart failure in this patient population.

Finerenone has been associated with reduced cardiovascular mortality and total worsening HF events across all BMI levels, with greater benefits observed in patients with higher BMIs.

Finerenone may be a beneficial treatment option for reducing cardiovascular risks in patients with varying BMI levels.

Lifestyle recommendations for nutritional care and physical activity in diabetes management are poorly implemented.

Practitioners should enhance the implementation of lifestyle interventions in diabetes care.

Semaglutide treatment following catheter ablation for atrial fibrillation is associated with a lower rate of atrial arrhythmia recurrence over 12 months (hazard ratio, 0.68; P =0.030).

Practitioners may consider semaglutide as a therapeutic option to reduce atrial arrhythmia recurrence post-ablation.

Semaglutide treatment led to larger reductions in glycated hemoglobin levels compared to the control group (−1.3% vs. −0.6%; P <0.001).

Semaglutide may improve glycemic control in patients post-ablation.

In men, a 14.4% ILI-associated increase in total testosterone at year 1 mediated increases in weight (189 g; 95% CI, 65-317) and waist circumference (0.135 cm; 95% CI, 0.19-0.248) at year 4.

Practitioners should consider the role of testosterone in managing weight and waist circumference in men with type 2 diabetes.

In women, a 21.8% decrease in bioavailable testosterone at year 1 mediated decreases in whole-body fat mass (-164; 95% CI, -326 to -29.3), whole-body lean mass (-115 g; 95% CI, -203.4 to -40), and trunk lean mass (-97.2 g; 95% CI, -156 to -45.5) at year 4.

Practitioners should consider the role of bioavailable testosterone in managing body composition in women with type 2 diabetes.

The study revealed sex-specific mediating effects of sex hormones due to weight loss from intensive lifestyle intervention on body composition changes in people with type 2 diabetes.

Practitioners should tailor weight loss recommendations based on sex differences in hormone responses.

Participants improved their accuracy in estimating repetitions in reserve (RIR) during the bench press over the intervention.

Improving RIR estimation can enhance training effectiveness and safety.

Tirzepatide is linked to a significantly reduced risk of overall hematologic malignancy (OR = 0.14, 95%CI = 0.03-0.60), particularly for lymphoma.

Tirzepatide may be a safer option for patients concerned about hematologic malignancies.

49% of patients receiving semaglutide treatment had a full stomach compared to 18% of matched controls.

Clinicians should be aware of the increased risk of full stomach in patients on semaglutide during pre-operative assessments.

Integrating shared decision-making (SDM) into obesity management enhances patient-centered care and has the potential to improve long-term outcomes.

Practitioners should consider incorporating SDM to enhance patient engagement and outcomes in obesity care.

Programs incorporating SDM reported improved patient engagement, satisfaction, and health outcomes across diverse demographic groups.

Incorporating SDM can lead to better patient experiences and outcomes in obesity management.

Common facilitators of SDM success include the use of decision aids, culturally tailored counseling, and multidisciplinary team involvement.

Healthcare providers should utilize decision aids and culturally tailored approaches to enhance SDM in obesity care.

Long-term intake of UPFs leads to addiction due to additives including fat, caffeine, and sugar.

Health professionals should consider the addictive potential of UPFs when advising clients.

Significant improvements were observed across quality-of-life scores.

Incorporating exercise and nutrition can enhance the quality of life for breast cancer patients.

Incretin mimetics have a positive impact on related comorbidities, such as sleep apnea and heart failure.

Practitioners should be aware of the broader health benefits of incretin mimetics beyond glucose control.